Stocks Gilead Sciences Inc


  • Stocks Drop as Dollar Rallies; GE Climbs Wednesday, 24 Mar 2010 | 2:31 PM ET

    Stocks fell Wednesday as a downgrade on Portugal's credit rating sent the dollar higher and stocks and commodities lower.

  • Pisani: Euro Slides; MF Global Soars Wednesday, 24 Mar 2010 | 11:29 AM ET

    European stocks weakened as Fitch downgraded Portugal's credit rating to AA- from AA, with a negative outlook. Predictably, this caused another drop in the euro, which is now at the lowest level against the dollar since May of last year.

  • Stocks Remain Lower After Home-Sales Miss Wednesday, 24 Mar 2010 | 11:01 AM ET

    Stocks remained lower Wednesday after a disappointing new-home sales report, but didn't add much to its losses. Stocks started the day lower after Portugal's credit rating was downgraded, accelerating jitters about European debt problems.

  • traders_1.jpg

    The Democrats' health care reform package could bring a dose of bad medicine for stocks if it passes this weekend, at least in the immediate term.

  • Why Are Options Bullish on Kellogg? Wednesday, 17 Mar 2010 | 7:50 AM ET

    Kellogg is drawing upside option activity as the food company's shares trade in an increasingly narrow range.

  • A Tale Of Two Sectors Tuesday, 9 Mar 2010 | 2:31 PM ET

    On the eve of the 10-year anniversary of the dot-com bubble bursting the stock stat mavens here at CNBC sliced and diced all sorts of data on share price performance since March 10, 2000.

  • Even Olympic Athletes Can't Seem To Save Wheaties Thursday, 4 Mar 2010 | 4:10 PM ET
    Lindsey Vonn featured on a box of Wheaties

    A couple of years ago, the folks at General Mills sensed trouble for its Wheaties, one of the oldest cereal franchises in the world. Athletes who used to say they would eat their Wheaties, no longer did. And so too followed a general public. Sales first flattened and then fell.

  • The Lightning Round is extended in this exclusive feature.

  • Cramer's Pulse on Friday's Market Friday, 26 Feb 2010 | 1:06 PM ET

    Get calls on Google, Joy Global, Biogen Idec and more.

  • Lightning Round: WellPoint, Prudential, Elan and More Thursday, 25 Feb 2010 | 11:54 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • A correction is “clearly on its way” since the start of the year, but investors can still make money in this market environment, said Enzio von Pfeil, CEO of He shared his market strategies.

  • Cramer’s Pulse on Tuesday’s Market Tuesday, 23 Feb 2010 | 3:17 PM ET

    Get calls on Apple, Seagate Tech, Cisco Systems and more.

  • The NASDAQ Composite is continuing to lead its peers.  Not only is the NASDAQ Composite up for its fifth consecutive day today, but the tech-driven index is also outperforming the major U.S. indexes month-to-date, up almost 4.3% as of late Thursday afternoon.

  • Cramer's Report Card on Stimulus Wednesday, 17 Feb 2010 | 2:26 PM ET

    Cramer interviews the White House economist Austan Goolsbee. Plus, get midday calls.

  • Cramer: Dealing With Greek Debt Tuesday, 9 Feb 2010 | 3:34 PM ET

    Plus, find out an even more powerful driver behind the markets these days.

  • Cramer makes the call on viewers' favorite stocks.

  • So far this year, the performance of the biotechnology index has been strong. So is there room for more growth in the sector? Mark Schoenebaum, managing director and senior research analyst at Deutsche Bank Securities shared his stock picks.

  • Big Pharma's Shot In The Arm Friday, 5 Feb 2010 | 2:41 PM ET

    I don't buy into the silly conspiracy theories that global health authorities worked in cahoots with the big, bad drug companies to gin up a pandemic scare just to goose vaccine and flu drug sales. Try telling that to the family of someone who died from H1N1.

  • The Shaky State Of California Biopharma Tuesday, 2 Feb 2010 | 3:21 PM ET

    Nearly every city and state wants biopharma. They fiercely compete for the relatively clean industry and the well-paid, highly educated jobs it brings.

  • Pfizer Earnings By the Numbers Tuesday, 2 Feb 2010 | 10:31 AM ET
    Pfizer headquarters in New York City.

    Pfizer, the world's largest drugmaker, is scheduled to report fourth-quarter results before the opening bell on Wednesday, February 3. Here is a look at how Pfizer shares traded during the most recent earnings reports.